Modulation of the T cell receptor beta chain repertoire after heart transplantation

被引:3
作者
Doumaid, K
van Miert, PPMC
Vaessen, LMB
Remmerswaal, EBM
Weimar, W
Boog, CJP
机构
[1] Univ Amsterdam, Acad Med Ctr, CLB, Dept Immunobiol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Lab Expt & Clin Immunol, NL-1105 AZ Amsterdam, Netherlands
[3] Acad Hosp Dijkzigt, Dept Internal Med 1, NL-3000 DR Rotterdam, Netherlands
关键词
T cell receptor; repertoire; transplantation; immunomodulation;
D O I
10.1016/S0966-3274(00)00008-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background : In a previous study it was shown that pre-transplant blood transfusion was associated with a better clinical outcome after heart transplantation (HTx). In this study the effect of heart transplantation (HTx) on the T cell receptor V beta chain (TCRV beta) repertoire was investigated. Therefore, we analyzed the TCRV beta repertoire of patients after HTx to see whether a correlation with clinical outcome could be observed. Methods: Patients were analyzed at four different time points: pre-HTx, less than 1 month post-Htx, between 1 month and 2.5 month post-Htx and more than 2.5 months post-HTx. CD4(+) and CD8(+) T cells were purified from patient peripheral blood mononuclear cells (PBMC). TCR beta chain usage was analyzed semiquantitatively by Southern blot analysis, Results: HTx affected the TCRV beta repertoire in both the CD4(+) and CD8(+) T cell compartments in all patients. Changes in the TCRV beta repertoire were most pronounced within the CD8(+) T cell subset. Interestingly, one patient showed modulation in TCRV beta chain usage predominantly in the CD4(+) T cell compartment. Conclusions: Modulation of TCRV beta chain usage was detected in all patients analyzed. No clear-cut relation was observed between TCRV beta modulation after transplantation and clinical outcome. In some cases modulations appeared to concur with observed immunological events (clinically and/or in-vitro). (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:83 / 94
页数:12
相关论文
共 21 条
[1]   Clinical role for a superantigen in Yersinia pseudotuberculosis infection [J].
Abe, J ;
Onimaru, M ;
Matsumoto, S ;
Noma, S ;
Baba, K ;
Ito, Y ;
Kohsaka, T ;
Takeda, T .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (08) :1823-1830
[2]  
Billingham M E, 1990, J Heart Transplant, V9, P587
[3]  
Billingham ME., 1982, HEART TRANSPLANTATIO, V1, P25
[4]   DETERMINATION OF CYTOTOXIC LYMPHOCYTE-T PRECURSOR FREQUENCIES USING EUROPIUM LABELING AS A NONRADIOACTIVE ALTERNATIVE TO LABELING WITH CHROMIUM-51 [J].
BOUMA, GJ ;
VANDERMEERPRINS, PMW ;
VANBREE, FPMJ ;
VANROOD, JJ ;
CLAAS, FHJ .
HUMAN IMMUNOLOGY, 1992, 35 (02) :85-92
[5]   Comparison of the V beta repertoire in peripheral blood and in lymph nodes of HIV-infected subjects reveals skewed usage predominantly in CD8(+) T cells [J].
Carbonari, M ;
Cibati, M ;
Pesce, AM ;
DellAnna, L ;
DOffizi, G ;
Angelici, A ;
Uccini, S ;
Fiorilli, M .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 81 (02) :200-209
[6]   FUNCTIONAL AND MOLECULAR CHARACTERIZATION OF GRAFT-INFILTRATING T-LYMPHOCYTES PROPAGATED FROM DIFFERENT BIOPSIES DERIVED FROM ONE HEART-TRANSPLANT PATIENT [J].
DATEMA, G ;
VAESSEN, LMB ;
DAANE, RC ;
BAAN, CC ;
WEIMAR, W ;
CLAAS, FHJ ;
VANDENELSEN, PJ .
TRANSPLANTATION, 1994, 57 (07) :1119-1126
[7]   Selection of T cell clones with restricted TCR-CDR3 lengths during in vitro and in vivo alloresponses [J].
Douillard, P ;
Josien, R ;
Pannetier, C ;
Bonneville, M ;
Soulillou, JP ;
Cuturi, MC .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (01) :71-83
[8]  
Flye MW, 1995, TRANSPLANTATION, V60, P1395
[9]  
GORSKI J, 1994, J IMMUNOL, V152, P5109
[10]  
Hall B L, 1993, Transpl Immunol, V1, P217, DOI 10.1016/0966-3274(93)90050-I